کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5888227 1152309 2013 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
MicroRNAs in HIV-associated nephropathy (HIVAN)
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی بیوشیمی بالینی
پیش نمایش صفحه اول مقاله
MicroRNAs in HIV-associated nephropathy (HIVAN)
چکیده انگلیسی

MicroRNAs (miRNAs) play a critical role in multiple biological and metabolic processes. Recent studies suggested that miRNAs are critical in the maintenance of glomerular homeostasis in both physiological and pathological states. However, the role of miRNAs in the pathogenesis of HIV-associated nephropathy (HIVAN) has not been studied. In the present study, we have used a microarray-based approach in combination with real-time PCR to profile the miRNA expression patterns in HIV-1 transgenic mice (Tg26). Our results showed that 13 miRNAs, which belong to 11 miRNA families, were downregulated in HIVAN when compared with control mice. These miRNAs were classified into 20 functional categories. In in vitro studies, we examined the expression of specific miRNAs in HIV-1 transduced human podocytes. Our results showed that HIV-1 downregulated miRNA expression, specifically of miR-200 and miR-33. These studies suggest that miRNAs contributed to the development of the proliferative phenotype of HIVAN. Further functional analysis of these miRNAs in HIVAN animal model will not only enhance understanding of the pathogenesis but would also lead to the development of therapeutic strategies for HIVAN patients.

► miRNAs are critical in the maintenance of glomerular homeostasis. ► Thirteen miRNAs, belonging to 11 miRNA families were downregulated in HIVAN. ► In in vitro studies, HIV-1 downregulated miRNA expression of miR-200 and miR-33. ► Thus, miRNAs contributed to the development of the proliferative phenotype of HIVAN.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Experimental and Molecular Pathology - Volume 94, Issue 1, February 2013, Pages 65-72
نویسندگان
, , , , , , , ,